<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03177408</url>
  </required_header>
  <id_info>
    <org_study_id>2017032901</org_study_id>
    <nct_id>NCT03177408</nct_id>
  </id_info>
  <brief_title>Impact of HMGB1 on Diastolic Dysfunction in Hypertensive Patients</brief_title>
  <official_title>Impact of HMGB1 on Diastolic Dysfunction in Hypertensive Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jing Li</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Affiliated Hospital of Hebei University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluated the association between HMGB1 and diastolic dysfunction in hypertensive
      patients. HMGB1 level were tested in all patients, and diastolic function determined by
      echocardiographic.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 15, 2017</start_date>
  <completion_date type="Anticipated">December 31, 2017</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Differences of HMGB1 levels between hypertensive patients with and without diastolic dysfunction</measure>
    <time_frame>on the day of admission</time_frame>
    <description>Blood samples of all individuals are collected on the day of admission and HMGB1 levels are tested. Echocardiographic assessment is performed with echocardiography device by using 2.5-3.5 Mega Hertz(MHz) transducer in the lateral decubitis position.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Differences of HMGB1 levels between grades of diastolic dysfunction</measure>
    <time_frame>on the day of admission</time_frame>
    <description>Blood samples of all individuals are collected on the day of admission and HMGB1 levels are tested. Echocardiographic assessment is performed with echocardiography device by using 2.5-3.5 Mega Hertz(MHz) transducer in the lateral decubitis position.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Diastolic Dysfunction</condition>
  <condition>Hypertension</condition>
  <condition>Inflammation</condition>
  <eligibility>
    <study_pop>
      <textblock>
        The study sample is recruited from the patients examined in the physical examination center
        of our hospital.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        All of the hypertensive patients in both diastolic dysfunction and control groups were
        either newly diagnosed or were aware of hypertension without using any pharmacotherapy.

        Exclusion Criteria:

        Individuals already under treatment for hypertension were not include.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 16, 2017</study_first_submitted>
  <study_first_submitted_qc>June 4, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 6, 2017</study_first_posted>
  <last_update_submitted>June 4, 2017</last_update_submitted>
  <last_update_submitted_qc>June 4, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Affiliated Hospital of Hebei University</investigator_affiliation>
    <investigator_full_name>Jing Li</investigator_full_name>
    <investigator_title>Doctor</investigator_title>
  </responsible_party>
  <keyword>Diastolic Dysfunction</keyword>
  <keyword>Hypertension</keyword>
  <keyword>HMGB1</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

